Latest news
27-02-2023 - Michael J Fox Foundation Issues New Call for Alpha-Synuclein Post-Translational Modification Quantification Program
Funding scheme to establish robust methods and tools that can quantify the amount and regional distribution of post-translational modifications of alpha-synuclein in Parkinson's disease-relevant brain regions.
Established in 2000, the Michael J Fox Foundation (MJFF) was set up to find a cure for Parkinson's disease (PD) and ensure the development of improved therapies.
[...]